Citations

Mayo Clinic

Clear

534 citation(s) found for "Ma, Chi".

Proteins Required for Centrosome Clustering in Cancer Cells
Leber, Blanka, Maier, Bettina, Fuchs, Florian , Riffel, Phillip, Anderhub, Simon, Wagner, Ludmila, Salisbury, Jeffrey L., Boutros, Michael , Krämer, Alwin , Chi, Jing , Riffel, Philipp, Ho, Anthony D.

Science Translational Medicine | May 26, 2010 | Volume: 2 | Issue: 33 | Pages: No page available

10.1126/scitranslmed.3000915 | PMID 20505215 Get It

Identified in an RNA interference screen, proteins that prevent spindle multipolarity in human cancer cells may prove to be promising drug targets.
Direct visualization of deep brain stimulation targets in Parkinson disease with the use of 7-tesla magnetic resonance imaging
Cho, Zang‐Hee , Min, Hoon‐Ki , Oh, Se‐Hong , Han, Jae-Yong, Park, Chan-Woong, Chi, Je-Geun, Kim, Young-Bo , Paek, Sun Ha , Lozano, Andrés M. , Lee, Kendall H. , Min, Hoon-Ki Paul

Journal of Neurosurgery | April 9, 2010 | Volume: 113 | Issue: 3 | Pages: 639-647

10.3171/2010.3.jns091385 | PMID 20380532 Get It

Object A challenge associated with deep brain stimulation (DBS) in treating advanced Parkinson disease (PD) is the direct visualization of brain nuclei, which often involves indirect approximations of stereotactic targets. In the present study, the authors compared T2*-weighted images obtained using 7-T MR imaging with those obtained using 1.5- and 3-T MR imaging to ascertain whether 7-T imaging enables better visualization of targets for DBS in PD. Methods The authors compared 1.5-, 3-, and 7-T MR images obtained in 11 healthy volunteers and 1 patient with PD. Results With 7-T imaging, distinct images of the brain were obtained, including the subthalamic nucleus (STN) and internal globus pallidus (GPi). Compared with the 1.5- and 3-T MR images of the STN and GPi, the 7-T MR images showed marked improvements in spatial resolution, tissue contrast, and signal-to-noise ratio. Conclusions Data in this study reveal the superiority of 7-T MR imaging for visualizing structures targeted for DBS in the management of PD. This finding suggests that by enabling the direct visualization of neural structures of interest, 7-T MR imaging could be a valuable aid in neurosurgical procedures.
Journal of Bone and Mineral Research
Heaney, Robert P., Deuxchaisnes, C Nagant de, Baylink, David J. , Johnston, C. Conrad, Joseph, Lini , Meunier, Pierre J., Murray, Timothy M.

Journal of Bone and Mineral Research | February 25, 2010 | Volume: 5 | Issue: S1 | Pages: S223-S225

10.1002/jbmr.5650051343 Get It

Regulation of Coronary Arterial BK Channels by Caveolae-Mediated Angiotensin II Signaling in Diabetes Mellitus
Lü, Tong , Zhang, Dai‐Min , Wang, Xiao-Li, He, Tongrong , Wang, Ruxing , Chai, Qiang , Katušić, Zvonimir S. , Lee, Hon-Chi, Wang, Xiao-Li, Lu, Tong

Circulation Research | February 19, 2010 | Volume: 106 | Issue: 6 | Pages: 1164-1173

10.1161/circresaha.109.209767 | PMID 20167931 Get It

Rationale : The large conductance Ca 2+ -activated K + (BK) channel, a key determinant of vascular tone, is regulated by angiotensin II (Ang II) type 1 receptor signaling. Upregulation of Ang II functions and downregulation of BK channel activities have been reported in diabetic vessels. However, the molecular mechanisms underlying Ang II-mediated BK channel modulation, especially in diabetes mellitus, have not been thoroughly examined. Objectives : The aim in this study was to determine whether caveolae-targeting facilitates BK channel dysfunction in diabetic vessels. Methods and Results : Using patch clamp techniques and molecular biological approaches, we found that BK channels, Ang II type 1 receptor, G αq/11 (G protein q/11 α subunit), nonphagocytic NAD(P)H oxidases (NOX-1), and c-Src kinases (c-Src) were colocalized in the caveolae of rat arterial smooth muscle cells and the integrity of caveolae in smooth muscle cells was critical for Ang II-mediated BK channel regulation. Most importantly, membrane microdomain targeting of these proteins was upregulated in the caveolae of streptozotocin-induced rat diabetic vessels, leading to enhanced Ang II-induced redox-mediated BK channel modification and causing BK channel and coronary dysfunction. The absence of caveolae abolished the effects of Ang II on vascular BK channel activity and preserved BK channel function in diabetes. Conclusions : These results identified a molecular scheme of receptor/enzyme/channel/caveolae microdomain complex that facilitates the development of vascular BK channel dysfunction in diabetes.
Induction of ectopic Myc target gene JAG2 augments hypoxic growth and tumorigenesis in a human B-cell model
Liu, Yen-Chun, Gao, Ping , Jie, Chunfa , Le, Anne , Vuica‐Ross, Milena , Bergsagel, P. Leif , Dang, Chi V. , Yustein, Jason Todd , Chng, Wee Joo , Eberhart, Charles G. , Bergsagel, P. Leif

Proceedings of the National Academy of Sciences | February 2, 2010 | Volume: 107 | Issue: 8 | Pages: 3534-3539

10.1073/pnas.0901230107 | PMID 20133585 Get It

Ectopic Myc expression plays a key role in human tumorigenesis, and Myc dose-dependent tumorigenesis has been well established in transgenic mice, but the Myc target genes that are dependent on Myc levels have not been well characterized. In this regard, we used the human P493-6 B cells, which have a preneoplastic state dependent on the Epstein–Barr viral EBNA2 protein and a neoplastic state with ectopic inducible Myc, to identify putative ectopic Myc target genes. Among the ectopic targets, JAG2 that encodes a Notch receptor ligand Jagged2, was directly induced by Myc. Inhibition of Notch signaling through RNAi targeting JAG2 or the γ-secretase Notch inhibitor N-[N-(3,5-difluorophenacetyl)-L-alanyl]-(S)-phenylglycine t-butyl ester (DAPT) preferentially inhibited the neoplastic state in vitro. Furthermore, P493-6 tumorigenesis was inhibited by DAPT in vivo. Ectopic expression of JAG2 did not enhance aerobic cell proliferation, but increased proliferation of hypoxic cells in vitro and significantly increased in vivo tumorigenesis. Furthermore, the expression of Jagged2 in P493-6 tumors often overlapped with regions of hypoxia. These observations suggest that Notch signaling downstream of Myc enables cells to adapt in the tumor hypoxic microenvironment.
Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C
Hsieh, Ting–Hui, Liu, Chun‐Jen , Lai, Ming–Yang, Chen, Pei‐Jer , Hsieh, Hsin-Ling , Chen, Ding‐Shinn , Kao, Jia‐Horng , Tseng, Tai‐Chung

Antiviral Therapy | November 27, 2009 | Volume: 14 | Issue: 8 | Pages: 1157-1163

10.3851/imp1454 | PMID 20032545 Get It

Background Hepatitis B virus (HBV) genotype B and C seem not to affect the therapeutic response to lamivudine (3TC). Whether a given genotype has an earlier emergence of 3TC resistance remains unclear. We thus conducted this study to elucidate the association of HBV genotype with the emergence of 3TC-resistant strains in Taiwanese patients. Methods Forty chronic hepatitis B patients who developed resistance after 3TC therapy were retrospectively enrolled. HBV genotype, serum alanine aminotransferase (ALT) and HBV DNA levels were determined at baseline. The presence of 3TC-resistant mutations was confirmed by direct sequencing whenever biochemical breakthrough developed. Results The distribution of HBV genotype B and C in 40 patients receiving 3TC therapy were 60% and 40%, respectively. The mean interval to detect 3TC- resistant strain was 19.6 ±1.7 months. By using multivariate analysis, HBV genotype B and higher pre-treatment HBV DNA level were independently associated with earlier detection of 3TC-resistant strains. In addition, genotype B was significantly associated with development of 3TC resistance within the first 12 months of 3TC therapy compared with genotype C (odds ratio 8.27; P=0.004). Conclusions Compared with HBV genotype C, genotype B appears to have an earlier biochemical resistance to 3TC than genotype C. Therefore, more frequent monitoring of viral load or genotypical resistance might be needed for patients with HBV genotype B infection receiving 3TC therapy, especially during the first year.
Vascular metallomics: Copper in the vasculature
Easter, Renee N., Chan, Qilin , Ritman, Erik L., Caruso, Joseph A. , Qin, Zhenyu , Lai, Barry Chi Hong

Vascular Medicine | October 6, 2009 | Volume: 15 | Issue: 1 | Pages: 61-69

10.1177/1358863x09346656 | PMID 19808712 Get It

Owing to recent progress in analytical techniques, metallomics are evolving from detecting distinct trace metals in a defined state to monitor the dynamic changes in the abundance and location of trace metals in vitro and in vivo. Vascular metallomics is an emerging field that studies the role of trace metals in vasculature. This review will introduce common metallomics techniques including atomic absorption spectrometry, inductively coupled plasma-atomic emission spectrometry, inductively coupled plasma-mass spectrometry and X-ray fluorescence spectrometry with a summary table to compare these techniques. Moreover, we will summarize recent research findings that have applied these techniques to human population studies in cardiovascular diseases, with a particular emphasis on the role of copper in these diseases. In order to address the issue of interdisciplinary studies between metallomics and vascular biology, we will review the progress of efforts to understand the role of copper in neovascularization. This recent advance in the metallomics field may be a powerful tool to elucidate the signaling pathways and specific biological functions of these trace metals. Finally, we summarize the evidence to support the notion that copper is a dynamic signaling molecule. As a future direction, vascular metallomics studies may lead to the identification of targets for diagnosis and therapy in cardiovascular disease.
The Snf1-related kinase, Hunk, is essential for mammary tumor metastasis
Wertheim, Gerald , Yang, Thomas, Ramne, Anna, Liu, Zhandong , Gardner, Heather Perry, Dugan, Katherine D., Kristel, Petra, Kreike, Bas , Vijver, Marc J. van de , Cardiff, Robert D. , Reynolds, Carol, Pan, Tien-Chi , Chodosh, Lewis A.

Proceedings of the National Academy of Sciences | August 28, 2009 | Volume: 106 | Issue: 37 | Pages: 15855-15860

10.1073/pnas.0906993106 | PMID 19717424 Get It

We previously identified a SNF1/AMPK-related protein kinase, Hunk, from a mammary tumor arising in an MMTV-neu transgenic mouse. The function of this kinase is unknown. Using targeted deletion in mice, we now demonstrate that Hunk is required for the metastasis of c-myc-induced mammary tumors, but is dispensable for normal development. Reconstitution experiments revealed that Hunk is sufficient to restore the metastatic potential of Hunk-deficient tumor cells, as well as defects in migration and invasion, and does so in a manner that requires its kinase activity. Consistent with a role for this kinase in the progression of human cancers, the human homologue of Hunk is overexpressed in aggressive subsets of carcinomas of the ovary, colon, and breast. In addition, a murine gene expression signature that distinguishes Hunk-wild type from Hunk-deficient mammary tumors predicts clinical outcome in women with breast cancer in a manner consistent with the pro-metastatic function of Hunk in mice. These findings identify a direct role for Hunk kinase activity in metastasis and establish an in vivo function for this kinase.
C-Lysine Conjugates: pH-Controlled Light-Activated Reagents for Efficient Double-Stranded DNA Cleavage with Implications for Cancer Therapy
Yang, Wang-Yong, Breiner, Boris, Kovalenko, Serguei V., Ben, Chi, Singh, Mani P., LeGrand, Shauna N., Sang, Qing‐Xiang Amy , Strouse, Geoffrey F. , Copland, John A. , Alabugin, Igor V.

Journal of the American Chemical Society | July 28, 2009 | Volume: 131 | Issue: 32 | Pages: 11458-11470

10.1021/ja902140m | PMID 19637922 Get It

Targeting Bone Remodeling for the Treatment of Osteoporosis: Summary of the Proceedings of an ASBMR Workshop
Bilezikian, John P. , Bellido, Teresita , Khosla, Sundeep , Martin, Jack W. , Recker, Robert R. , Heaney, Robert P., Seeman, Ego , Papapoulos, Socrates E. , Goldring, Steven R., Matsumoto, Toshio , Khosla, Sundeep

Journal of Bone and Mineral Research | March 4, 2009 | Volume: 24 | Issue: 3 | Pages: 373-385

10.1359/jbmr.090105 | PMID 19260805 Get It